Related Experiment Video
Updated: Jun 16, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells
Mythily Mariasegaram1, Greg H Tesch, Sarah Verhardt
1Department of Nephrology, Monash University, Monash Medical Centre, Clayton, Vic., Australia.
Abstract:
Lefty is a novel member of the transforming growth factor (TGF) supergene family which has the potential to antagonise actions of TGF-beta1 - the main factor driving fibrotic disease in the kidney and in other organs. TGF-beta1 can induce fibrosis through several mechanisms, including epithelial-mesenchymal transition (EMT) which contributes to myofibroblast accumulation in the renal interstitium. This study examined whether Lefty can antagonise TGF-beta1 mediated EMT. A rat tubular epithelial cell line (NRK52E) was stably transfected with a Lefty expression plasmid (52E-Lefty) or control plasmid (52E-Control). 52E-Control cells underwent TGF-beta1 induced EMT with up-regulation of alpha-smooth muscle actin (alpha-SMA), down-regulation of E-cadherin, and transition to an elongated fibroblast-like morphology. In contrast, 52E-Lefty cells were substantially protected from TGF-beta1 induced EMT. Analysis of signalling pathways showed that 52E-Lefty cells had a marked reduction in TGF-beta1 induced Smad activity and suppression of the secondary phase of JNK (but not p38) signalling. Treatment of NRK52E cells with a JNK inhibitor was shown to suppress TGF-beta1 induced EMT. In conclusion, Lefty can antagonise TGF-beta1 mediated EMT in renal tubular epithelial cells. Lefty may have potential as an anti-fibrotic molecule in the treatment of renal fibrosis.
Insights
Lefty protein can block transforming growth factor-beta1 (TGF-beta1) from causing kidney fibrosis by preventing epithelial-mesenchymal transition (EMT). This finding suggests Lefty
Area of Science:
- Molecular Biology
- Cell Biology
- Renal Physiology
Background:
- Transforming growth factor-beta1 (TGF-beta1) drives fibrotic diseases.
- TGF-beta1 induces kidney fibrosis via epithelial-mesenchymal transition (EMT).
- Lefty, a TGF supergene family member, may antagonize TGF-beta1 actions.
Purpose of the Study:
- To investigate if Lefty can antagonize TGF-beta1-induced EMT in renal tubular epithelial cells.
- To explore the underlying molecular mechanisms of Lefty's action.
Main Methods:
- Stable transfection of rat tubular epithelial cells (NRK52E) with Lefty expression plasmid.
- Exposure to TGF-beta1 to induce EMT.
- Analysis of EMT markers (alpha-SMA, E-cadherin) and cell morphology.
- Assessment of intracellular signaling pathways (Smad, JNK, p38).
Main Results:
- Lefty-expressing cells (52E-Lefty) were protected from TGF-beta1-induced EMT.
- Lefty significantly reduced TGF-beta1-induced Smad activity.
- Lefty suppressed the secondary phase of JNK signaling, but not p38.
- JNK inhibition also suppressed TGF-beta1-induced EMT.
Conclusions:
- Lefty antagonizes TGF-beta1-mediated EMT in renal tubular epithelial cells.
- Lefty demonstrates potential as an anti-fibrotic therapeutic agent for kidney fibrosis.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway

